131 related articles for article (PubMed ID: 24315238)
1. [Sunitinib-induced pyoderma gangrenosum].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2013 Dec; 140(12):841-2. PubMed ID: 24315238
[No Abstract] [Full Text] [Related]
2. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
3. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum: another cutaneous side-effect of sunitinib?
ten Freyhaus K; Homey B; Bieber T; Wilsmann-Theis D
Br J Dermatol; 2008 Jul; 159(1):242-3. PubMed ID: 18489600
[No Abstract] [Full Text] [Related]
5. Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
Kuntz T; Koushk-Jalali B; Kreuter A
CMAJ; 2020 May; 192(20):E552. PubMed ID: 32452467
[No Abstract] [Full Text] [Related]
6. Sunitinib induced pyoderma gangrenosum-like ulcerations.
Akanay-Diesel S; Hoff NP; Kürle S; Haes J; Erhardt A; Häussinger D; Schulte KW; Bölke E; Matuschek C; Budach W; Gerber PA; Homey B
Eur J Med Res; 2011 Nov; 16(11):491-4. PubMed ID: 22027642
[TBL] [Abstract][Full Text] [Related]
7. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi MM; Kadry R; Mitwali H
J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
[No Abstract] [Full Text] [Related]
8. Pyoderma Gangrenosum Associated with Sunitinib: A Case Report.
Sevimli Dikicier B
Adv Skin Wound Care; 2019 Sep; 32(9):427-429. PubMed ID: 31408027
[TBL] [Abstract][Full Text] [Related]
9. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yıldız I; Varol U; Şen F; Kılıç L
Anadolu Kardiyol Derg; 2014 Nov; 14(7):654-6. PubMed ID: 25163084
[No Abstract] [Full Text] [Related]
10. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
O'Donnell PH
BJU Int; 2011 Oct; 108(8):1284-5. PubMed ID: 21418138
[No Abstract] [Full Text] [Related]
11. Re: Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
van den Meiracker AH; Danser AH; Sleijfer S; Kappers MH
J Natl Cancer Inst; 2011 Oct; 103(20):1557; author reply 1558. PubMed ID: 21862728
[No Abstract] [Full Text] [Related]
12. Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Kalantari HR
Br J Cancer; 2009 Oct; 101(7):1222-3; author reply 1224. PubMed ID: 19755985
[No Abstract] [Full Text] [Related]
13. Acute cardiac failure after sunitinib.
Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
[No Abstract] [Full Text] [Related]
14. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Feldman DR; Martorella AJ; Robbins RJ; Motzer RJ
J Natl Cancer Inst; 2007 Jun; 99(12):974-5; author reply 976-7. PubMed ID: 17565156
[No Abstract] [Full Text] [Related]
15. Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.
Garfield DH; Hercbergs A; Davis PJ
J Natl Cancer Inst; 2007 Jun; 99(12):975-6; author reply 976-7. PubMed ID: 17565154
[No Abstract] [Full Text] [Related]
16. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
17. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
Daniels GH
Clin Endocrinol (Oxf); 2009 Sep; 71(3):455. PubMed ID: 19138312
[No Abstract] [Full Text] [Related]
18. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
van der Veldt AA; van den Eertwegh AJ; Hoekman K; Barkhof F; Boven E
Ann Oncol; 2007 Oct; 18(10):1747-50. PubMed ID: 17890217
[No Abstract] [Full Text] [Related]
19. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.
Tsai KY; Yang CH; Kuo TT; Hong HS; Chang JW
J Clin Oncol; 2006 Dec; 24(36):5786-8. PubMed ID: 17179114
[No Abstract] [Full Text] [Related]
20. How does sunitinib cause hypothyroidism?
Hershman JM; Liwanpo L
Thyroid; 2010 Mar; 20(3):243-4. PubMed ID: 20187779
[No Abstract] [Full Text] [Related]
[Next] [New Search]